The major goal in organ transplantation is to prevent rejection yet preserve the immunocompetence of the recipient.Nonspecific immunosuppressive agents are currently the only method available to prevent rejection.Because of their mechanism of action,an increased rate of infection and malignancy accompanies their use.To overcome these limitations, attempts have been made to induce donor specific transplantation tolerance with preservation of immunocompetence.Although fully allogeneic chimeras (A=>B) are tolerant, they exhibit failure of engraftment,poor immunocompetence,and are prone to graft versus host (GVH) disease.We have developed a model for MIXED ALLOGENEIC RECONSTITUTION in which T-cell depleted (TCD) syngeneic plus TCD allogeneic bone marrow are transplanted into an lethally irradited recipient.Engraftment is reliable, tolerance induction occurs in 100% of recipients, the immunocompetence of the mixed chimeras is superior,and recipient animals are resistant to GVH disease.We have observed that both host and donor factors play a role in the balance of engraftment of allogeneic bone marrow stem cells.The model we have developed will be exploited to identify and subsequently isolate THE CRITICAL CELL(S) OF BOTH HOST AND DONOR TYPE WHICH FACILITATE ENGRAFTMENT OF ALLOGENEIC BONE MARROW STEM CELLS.There is data to suggest that T-cells are essential for stem cell engraftment.Initially,we will focus on those allogeneic donor bone marrow cell(s) which facilitate engraftment of allogeneic stem cells [FACILITATORY CELL].Once the FACILITATORY CELL is identified,we propose to ISOLATE IT AND CO-ADMINISTER IT WITH PURIFIED STEM CELLS PLUS T-CELL DEPLETED SYNGENEIC BONE MARROW TO ACHIEVE MIXED CHIMERISM AND TOLERANCE (Specific Aim 2).We will characterize the production of INTERLEUKINS and COLONY STIMULATING FACTORS in an attempt to determine whether these soluble factors can SUBSTITUTE FOR THE FACILITATORY CELL in facilitation of allogeneic stem cell engraftment.We will then focus on the SYNGENEIC host cells which,when present,PREVENT ENGRAFTMENT of allogeneic donor bone marrow stem cells (Specific Aim 3),AND APPLY THE KNOWLEDGE obtained to preparation of ANTIBODY-FACILITATED MIXED CHIMERAS.What we are seeking is a method to allow the induction of MIXED ALLOGENEIC CHIMERISM,WITH ITS ACCOMPANYING ADVANTAGES OF SUPERIOR IMMUNOCOMPETENCE AND RESISTANCE TO GVH DISEASE IN ADDITION TO SPECIFIC TOLERANCE, USING ONLY MONOCLONAL ANTIBODY CONDITIONING.In effect, a focused, component approach will be applied to engraftment and tolerance induction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030615-03
Application #
3145670
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-07-01
Project End
1996-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Colson, Y L; Schuchert, M J; Ildstad, S T (2000) The abrogation of allosensitization following the induction of mixed allogeneic chimerism. J Immunol 165:637-44
Colson, Y L; Tripp, R A; Doherty, P C et al. (1998) Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. J Immunol 160:3790-6
Kaufman, C L; Li, H; Ildstad, S T (1997) Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J Immunol 158:2435-42
Colson, Y L; Li, H; Boggs, S S et al. (1996) Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 157:2820-9
Li, H; Kaufman, C L; Boggs, S S et al. (1996) Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 156:380-8
Li, H; Colson, Y L; Ildstad, S T (1995) Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 60:523-9
Woo, J; Thomson, A W; Ildstad, S T (1995) Effects of FK 506 on chimerism and the induction of donor-specific unresponsiveness following fully allogeneic bone marrow transplantation in mice. Transpl Immunol 3:86-90
Brissette-Storkus, C; Appasamy, P M; Hayes, L A et al. (1995) Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines. Nat Immun 14:98-113
Li, H; Abou el-Ezz, A Y; Gambrell, B E et al. (1995) Mixed xenogeneic chimerism and tolerance III. A nonlethal approach to induce donor-specific transplantation tolerance to simultaneous islet xenografts. Transplantation 60:59-65
Li, H; Kaufman, C L; Ildstad, S T (1995) Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 118:192-7;discussion 197-8

Showing the most recent 10 out of 29 publications